Is the treatment of glaucoma limited to topical drops only?

Simple item record

Full item record

dc.contributor.authorDyda, Maciej
dc.contributor.authorKręcicka, Maria
dc.contributor.authorDrewniowska, Julia
dc.contributor.authorGóral, Magdalena
dc.contributor.authorCugier, Olgierd
dc.contributor.authorZając-Pytrus, Hanna
dc.contributor.organizationFaculty of Medicine, Wrocław Medical University, Wrocław, Poland
dc.contributor.organizationDepartment of Ophthalmology, Wrocław Medical University, Wrocław, Poland
dc.date.accessioned2025-01-27T11:19:53Z
dc.date.available2025-01-27T11:19:53Z
dc.date.issued2025-01-09
dc.description.abstractGlaucoma is a degenerative condition characterized by progressive loss of retinal ganglion cells, leading to irreversible vision loss. This review aims to summarize the current knowledge about treatment strategies that optimize and improve glaucoma patients’ outcomes. We explored various therapeutic options for glaucoma, highlighting the importance of methods beyond the traditional topical eye drops. We discussed the pharmacological options, as well as the more individualized treatment approaches e.g. surgical interventions and laser therapy. Moreover, we described the role of neuroprotection (e.g. antioxidants, anti-inflammatory agents, NMDAR inhibitors). Further research is needed to confirm the efficacy and safety of these neuroprotective agents. Regarding neovascular glaucoma, we focused on anti-VEGF agents and panretinal photocoagulation. Finally, we analyzed the potential adjunctive role of statins in the treatment of glaucoma. Although there is conflicting evidence regarding the efficacy of statins as a potential adjunctive glaucoma treatment, recent studies suggest possible benefits of this therapy.en
dc.identifier.citationDyda M., Kręcicka M., Drewniowska J., Góral M., Cugier O., Zając-Pytrus H. Is the treatment of glaucoma limited to topical drops only? Eur J Transl Clin Med 2024;7(2):111-121. https://doi.org/10.31373/ejtcm/196849
dc.identifier.doi10.31373/ejtcm/196849
dc.identifier.issn2657-3156
dc.identifier.urihttps://open.icm.edu.pl/handle/123456789/25318
dc.language.isoen
dc.publisherGdański Uniwersytet Medyczny
dc.rightsUznanie autorstwa-Na tych samych warunkach 4.0 Międzynarodoween
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/
dc.sourceEuropean Journal of Translational and Clinical Medicine
dc.subjectglaucomaen
dc.subjectimplantsen
dc.subjectneovascularen
dc.subjectMIGSen
dc.titleIs the treatment of glaucoma limited to topical drops only?en
dc.typearticle
dc.type.versionpublishedVersion
person.identifier.orcidDyda, Maciej [0000-0001-5574-7628]
person.identifier.orcidZając-Pytrus, Hanna [0000-0003-0165-5108]
Files for this record
Original bundle
Now showing 1 - 1 of 1
Name: EJTCM_2024_7_2_Dyda.pdf
Size: 508.54 KB
Format: Adobe Portable Document Format
Description:
Download
License files
Name: license_rdf
Size: 1.13 KB
Format: RDF serialized in XML
Description:
Download
Belongs to collection
Artykuły / Articles